Cergentis
Menu

Complete Transgene Integration Site Characterization for Producer Cell Banks and Immunotherapy Products

12 November 2020Webinars

REGISTER HERE

 

LIVE webinar covering the latest developments in the use of the Targeted Locus Amplification (TLA) technology for upstream and downstream cell and gene therapy product development and production.

 

During this webinar, the following subjects will be discussed:

  • Introduction to Targeted Locus Amplification (TLA) technology
  • Viral vector producing MCB characterization
  • Characterization of immunotherapy products

 

The webinar will be concluded with a Q&A.

 

Your host: Allan La, MSc - International Sales Manager at Cergentis

 

REGISTER HERE

* Not available at the time of the webinar? Sign up to receive a link to the recording afterwards.

 

 

 

 

 

 

Overview
© 2012-2020 Cergentis B.V. All rights reserved.
For Research Use Only.Not for use in diagnostic procedures.